Evidence map›Paper›PMID 35769102›Full record

ArticleFrontiers in bioengineering and biotechnology2022

Electron-Beam Irradiated Recombinant Human Collagen-Phosphorylcholine Corneal Implants Retain Pro-Regeneration Capacity.

Fiona C Simpson, Mohammed Mirazul Islam, Oleksiy Buznyk, Elle Edin, Marc Groleau, Monika Kozak-Ljunggren, Federica M Magrelli, Dina B AbuSamra, Pablo Argüeso, James Chodosh and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 5 countries.

Fiona C SimpsonDepartment of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Mohammed Mirazul IslamDepartment of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Oleksiy BuznykDepartment of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Elle EdinDepartment of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Marc GroleauMaisonneuve-Rosemont Hospital Research Centre, Montréal, QC, Canada.
Monika Kozak-LjunggrenDepartment of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Federica M MagrelliInterdepartmental Centre for Regenerative Medicine "Stefano Ferrari", University of Modena and Reggio Emilia, Modena, Italy.
Dina B AbuSamraDepartment of Ophthalmology, Massachusetts Eye and Ear and Schepens Eye Research Institute, Harvard Medical School, Boston, MA, United States.
Pablo ArgüesoDepartment of Ophthalmology, Massachusetts Eye and Ear and Schepens Eye Research Institute, Harvard Medical School, Boston, MA, United States.
James ChodoshDepartment of Ophthalmology, Massachusetts Eye and Ear and Schepens Eye Research Institute, Harvard Medical School, Boston, MA, United States.
Aneta LiszkaDepartment of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Per FagerholmDepartment of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
May GriffithDepartment of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Linköping University · SEHarvard University · USCentre Hospitalier de l’Université de Montréal · CAFerrari (Italy) · ITFilatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine · UAHôpital Maisonneuve-Rosemont · CASmith-Kettlewell Eye Research Institute · US

Funding

Mesenchymal Stem Cells can Restore and Maintain Corneal Endothelial FunctionR00EY031373 · NEI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Mohammad Mirazul Islam · 2024 to 2026
$746k
Mesenchymal Stem Cells can Restore and Maintain Corneal Endothelial FunctionK99EY031373 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI ISLAM, MOHAMMAD MIRAZUL · 2021 to 2022
$213k
NEI NIH HHS K99 EY031373NEI NIH HHS R00 EY031373
6 · The paper itself

Abstract

Sterilization of biodegradable, collagen-based implants is challenging as irradiation sterilization methods can alter their mechanical properties. Electron beam (EB) irradiation is a terminal sterilization method that has been used for biologically-derived implants. Here, recombinant human collagen type III-phosphorylcholine (RHCIII-MPC) hydrogels were irradiated with EB doses of 17, 19, or 21 kGy and their subsequent biocompatibility and ability to promote regeneration in rabbit corneas was evaluated. Unirradiated hydrogels stored in 1% chloroform in phosphate-buffered saline (C-PBS) were the controls. There were no significant differences between irradiated and non-irradiated samples in optical or physical properties (tensile strength, modulus, elasticity), or the ability to support cell growth. However, irradiated implants were more sensitive to high levels of collagenase than unirradiated controls and the C-PBS implants had increased cell growth compared to EB and controls at 72 h. Corneal implants e-beamed at 17 kGy or e-beamed and subsequently frozen (EB-F) to increase shelf-life showed no adverse biological effects of the irradiation. EB, EB-F, and C-PBS implanted corneas all rapidly re-epithelialized but showed mild neovascularization that resolved over 6 months. The regenerated neo-corneas were transparent at 6 months post-operation.

Indexed as

collagencorneaE-beamimplantirradiationrabbits

Identifiers

PMID35769102
PMCPMC9234199
OpenAlexW4282574056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.